Efficacy and safety of combined fractional ablative CO2 laser and 5 fluorouracil in the treatment of acral vitiligo: An open, uncontrolled study

J Cosmet Dermatol. 2022 Nov;21(11):5636-5641. doi: 10.1111/jocd.15116. Epub 2022 Jun 7.

Abstract

Background: Acral lesions of vitiligo are most likely recalcitrant to the known lines of treatment. Ablative fractional CO2 has shown efficacy in treatment of vitiligo in combination with other modalities.

Methods: Thirty non-segmental vitiligo patients with acral lesion were included in the study. Each patient was subjected to fractional Carbon Dioxide Laser Treatment followed by application of 5 fluorouracil (5FU) cream for five consecutive days. Evaluation was done 3 weeks from the start of treatment and 12 weeks after the last treatment session using VESTA score, evaluation of patients' photos by blinded investigation in addition to patients' satisfaction scores.

Results: Patients showed significant improvement of Vitiligo extent score for a target area (VESTA) score and developed considerable degree of repigmentation as assessed by blinded investigators.

Conclusion: The combination of fractional ablative CO2 and 5FU is an effective and safe procedure for the treatment of acral vitiligo with promising results offering patients a new therapeutic window.

Keywords: 5FU; Acral vitiligo; Fractional CO2; VESTA score; recalcitrant.

MeSH terms

  • Carbon Dioxide / adverse effects
  • Combined Modality Therapy
  • Fluorouracil / adverse effects
  • Humans
  • Lasers, Gas* / adverse effects
  • Treatment Outcome
  • Ultraviolet Therapy* / methods
  • Vitiligo* / diagnosis
  • Vitiligo* / therapy

Substances

  • Carbon Dioxide
  • Fluorouracil